Sort
39,280 grants matching “leukemia”
Inactivating EVI1 for the Treatment of Myelodysplastic *
$367,420Giuseppina Nucifora · University Of Illinois At Chicago · R01 · FY2007 · HL
A Mouse Model of Myelodysplastic Syndrome Progression
$367,420Giuseppina Nucifora · University Of Illinois At Chicago · R01 · FY2008 · HL
A Mouse Model of Myelodysplastic Syndrome Progression
$367,420Giuseppina Nucifora · University Of Illinois At Chicago · R01 · FY2009 · HL
Internet CareLink for Pediatric Home Chemotherapy
$367,416Clinician Support Technology, Inc. · R44 · FY2003 · CA
Understanding T Cell Rapamycin Resistance
$367,403Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Combination Gene Therapy and Th1Th2 Therapy
$367,403Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Microbiology and Virology Core
$367,379Michael J Boeckh · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
The Role of Zinc Finger Genes in Leukemogenesis
$367,370Sinisa Dovat · University Of Wisconsin-Madison · R01 · FY2009 · HL
The Role of Zinc Finger Genes in Leukemogenesis
$367,370Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · HL
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia
$367,346Michael L Cleary · Stanford University · R01 · FY2020 · CA
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
$367,335Dorothy A Sipkins · Duke University · R01 · FY2020 · CA
Ikaros regulation: study on hemo-lymphopoiesis
$367,275Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2011 · CA
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN
$367,236Washington University · R01 · FY2000 · AG
Core - Clinical Res. Operations - Leadership
$367,216Edward J Benz · Dana-Farber Cancer Inst · P30 · FY2007 · CA
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia
$367,205Michael L Cleary · Stanford University · R01 · FY2021 · CA
Biostatistics
$367,182Barry E Storer · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Biostatistics
$367,182Barry E Storer · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Biostatistics
$367,182Barry E Storer · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA
Development of Chimeric Antigen Receptors Targeting Multiple Myeloma
$367,151James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
New Chimeric Antigen Receptors for Treating Hematologic Malignancies
$367,151James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Project 1: Targeting the MYC Pathway in Prostate Cancer
$367,114Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2024 · CA
HUMORAL REGULATION OF NORMAL AND MALIGNANT HEMATOPOIESIS
$366,985Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · CA
MicroRNA Regulates Graft-versus-Host Disease
$366,977Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2018 · AI
CTCL immunobiology: lessons from alemtuzumab
$366,977Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2016 · AR
CTCL immunobiology: lessons from alemtuzumab
$366,977Rachael Ann Clark · Brigham And Women'S Hospital · R01 · FY2017 · AR